FDA
approval
· 2022-06-22
FDA Approved: VIGABATRIN — Original Application (Amneal Pharmaceuticals NY LLC)
Summary
FDA approves the original ANDA for Vigabatrin (Amneal Pharmaceuticals NY LLC) for the treatment of infantile spasms and refractory complex partial seizures.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VIGABATRIN (VIGABATRIN)